← Back to Rankings

TSCOTractor Supply Company

Fundamentals Score: 37.9/100 (Weak Fundamentals) · Consumer Cyclical

Description

Tractor Supply Company functions as a prominent retailer, catering to the rural lifestyle demographic throughout the United States. Its extensive product catalog encompasses items crucial for the health, well-being, development, and enclosure of equine, livestock, pets, and small animals.

Score Breakdown

Growth
27.5/100
weight: 45%
Quality / Profitability
50.9/100
weight: 40%
Financial Health
34.7/100
weight: 15%
Valuation Context (informational only — not part of the score)
Cheap vs. its own history
Entry Timing (informational only — not part of the score)
Neutral

Live Market DataPrice updated: 12h ago

P/E (TTM)
18.2
Yield
2.64%
RSI (14)
56.7
vs SMA20
-0.46%
vs SMA50
+6.84%
vs SMA200
-16.45%
Analyst Target
$37
+4.6%
20 analysts
AI Theoretical Price
$36
+2.9%
as of 2026-08-27

AI Deep-Dive Analysis

Analysis as of 2026-08-27 - price/technical figures below reflect that date, not live market data

As of 2026-08-27, Tractor Supply trades at $34.70 — near the low end of its $28.36–$62.87 52-week range, with RSI at 55.35 and a consensus Hold. Q2 FY2026 comps were -1.5%, full-year guidance was cut, and the stock is cheap versus its own history but lacks a confirmed earnings inflection.

AI Sentiment:Neutral

Market mood is cautious-neutral: reported Q2 EPS of $0.69 missed, adjusted EPS of $0.81 was a penny shy of consensus, comps fell 1.5%, and management cut FY2026 guidance. Offsetting that are a 20bp improvement in adjusted gross margin, $500M debt refinancing, CEO insider buying of 15,600 shares, and a consensus price target of $37 — so the stock is being neither chased nor abandoned.

Quarterly Trend

Revenue growth decelerated from +4.5% YoY in Q2'25 to +2.3% in Q2'26, after an unsustained bounce to +7.2% in Q3'25; Q2'26 comps were -1.5%. Reported operating margin fell from 13.0% in Q2'25 to 11.7% in Q2'26, and reported EPS dropped from $0.81 to $0.69. Because Q2'26 included Petsense/VIP Petcare restructuring charges, the underlying erosion is less severe than reported; this looks like a decelerating/trough quarter, not yet a proven recovery.

Valuation Assessment

At $34.70, the stock trades at 18.1x trailing EPS and roughly 18x forward EPS of $1.93, versus a 5-year average P/E of 24.6x. Price/sales is 1.16x versus a 5-year average of 1.85x. The PEG ratio is negative and not meaningful given flat earnings growth. In short: inexpensive versus its own history, but only fair on an absolute basis unless EPS stabilizes — the market is already assuming no growth.

Price vs. Earnings Playbook

The price has already done the de-rating work: from 24.6x average P/E to 18.1x, with forward EPS essentially identical to trailing EPS ($1.93). The market is pricing a no-growth, mature retailer, not a turnaround. If Q3 comps and the back-half guidance hold up, this low multiple leaves room for a re-rating; if EPS estimates are cut again, the stock can look cheap for a reason. The swing factor is earnings direction, not multiple compression.

Technical Picture

As of 2026-08-27, RSI(14) is 55.35 — neutral, not oversold or overbought. Price is +0.25% above its 20-day SMA and +7.83% above its 50-day, but -18.35% below the 200-day SMA. That is a short-term basing/stabilization attempt inside a longer-term downtrend, not an uptrend. A confirmed entry would need a reclaim of the 200-day or another higher low near the 50-day.

Macro Factors
  • Rural/middle-income consumer strain is compressing discretionary, big-ticket spending, hitting items like riding mowers and premium equipment.
  • Tariff and product-cost environment: Q2'26 adjusted gross margin improved 20bp partly due to tariff/cost management, but additional tariffs could reverse that tailwind.
  • Interest rates: higher financing costs weigh on big-ticket purchases and on TSCO's own debt service after the $500M senior notes offering.
  • Pet-care and services expansion: VIP Petcare, Allivet, and the Instacart delivery partnership broaden the total addressable market and add recurring revenue.
  • Omnichannel competition from Amazon and big-box retailers pressures hard goods, while TSCO leans on its rural assortment and local convenience.
Key Catalysts
  • Barclays Global Consumer Staples Conference on Sept 9, 2026 — management can reassure investors on back-half margins and EPS trajectory.
  • Q3'26 comps and autumn promotional events like Spooky Season and Animal Days will show whether May's sales softness was a blip or a trend.
  • Petsense restructuring and VIP Petcare/Allivet integration could generate measurable cost savings and incremental revenue.
  • Any Fed rate cut would lower financing costs for big-ticket purchases and could revive demand.
  • Further insider buying or a guidance raise would be a strong confidence signal.
Key Risks
  • Comps stay negative into Q3/Q4 as consumer softness broadens, forcing another guidance cut.
  • Margin pressure from promotions, freight, and labor costs outweighs tariff/cost-productivity gains.
  • Leverage is elevated: reported debt/equity is 2.49 and the new $500M notes add interest expense if sales stall.
  • Petsense/VIP Petcare integration fails to deliver expected synergies or becomes a management distraction.
  • Weather/seasonality: a weak fall selling season is hard to make up later in the year.
Investment Thesis

As of 2026-08-27, this is not a compelling buy. The balance sheet is more levered than the headline metrics suggest, comps are negative, and management cut guidance; but cash generation remains solid, accruals are negative (a good earnings-quality sign), and the valuation is cheap relative to history. I would put TSCO on a watchlist and wait for Q3 comps and guidance to turn before committing — it is closer to a value trap than a value opportunity until the operating trend inflects.

AI Theoretical Price Methodology

I applied an 18.6x multiple to the next-FY EPS estimate of $1.933 — a ~24% discount to TSCO's 5-year average P/E of 24.6x, justified by flat EPS growth and negative comps — and cross-checked it against a ~1.2x price/sales multiple. That yields roughly $36.00, marginally above the current price and below the $37 consensus target.

AI Lean: Cautiously BearishConfidence: Medium

AI Review of the Deterministic Score

Partially Agree

The deterministic 37.9 'Weak Fundamentals' score is directionally right but a little too harsh. The formula is backward-looking and mechanically punished Q2'26's reported results, which included one-off Petsense/VIP Petcare charges; adjusted gross margin improved, TTM operating cash flow of ~$1.29B is well above TTM net income of ~$1.01B, and the accruals ratio is negative (-1.66%), signaling decent earnings quality. I would nudge the score into the low-to-mid 40s, but it stays in the Weak band because revenue growth is decelerating and leverage is elevated. Hence Partially Agree, not full agreement.

AI-generated analysis for informational purposes only, not financial advice.